MedTrace Logo

T-ICD vs S-ICD Shocks: Myocardial Injuries

NCT03458065 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-03-08

No results posted yet for this study

Summary

Implantable cardioverter defibrillator (ICD) shocks are associated with a subsequent increased risk of death, and an elevation of cardiac enzymes has been measured after defibrillation testing (DFT). The aim of our study was to investigate the association between S-ICD vs T-ICD shocks and acute cardiac damage in humans, as evaluated by means of sensitive and highly specific circulating biomarkers

Conditions

  • ICD Shock Myocardial Injuries

Interventions

DEVICE

ICD

Implantable Cardioverter Defibrillator

Sponsors & Collaborators

  • Monaldi Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-09-01
Completion
2019-03-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03458065 on ClinicalTrials.gov